Epstein Secrets

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

police said the "funeral attendees exchanged gunfire with those" inside a passing vehicle. Police Officers Attacked As Seattle Protests Continue. The Washington Examiner <https://wwvv.washingtonexaminer.corn/news/a-dozen-officers-attacked-by-violent- protesters-as-unrest-in-seattle-continues> (7/21, Mastrangelo, 448K)

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

plications, it only claimed that those inaccuracies did not ultimately affect the outcome of the Foreign Intelligence Surveillance Court's orders." The Washington Examiner <https://www.washingtonexaminer.corn/news/fbi-review-indicates-carter-page-fisa- was-especially-problematic> (7/30, Dunleavy, 448K) reports that surv

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

I have no reason to think that was not the correct decision,' Garland said, adding that he does `have to have an opportunity to talk with' Durham." The Washington Examiner (2/22, Dunleavy, 888K) reports that Grassley "asked Garland if he was saying that Durham would only be removed 'for cause.' Garland didn't commit to

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

quickly nominate someone highly skilled as national cyber director." Commerce Secretary Nominee Won't Promise To Maintain Huawei On US Blacklist. The Washington Examiner (1/26, Dunleavy, 888K) reports President Biden's nominee to "lead the Commerce Department would not commit to keeping Huawei on the US entities blac

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

plications, it only claimed that those inaccuracies did not ultimately affect the outcome of the Foreign Intelligence Surveillance Court's orders." The Washington Examiner (7/30, Dunleavy, 448K) reports that surveillance of former Trump campaign adviser Carter Page "appears to have been uniquely problematic." The FBI

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

and other minorities are denied equal treatment in the criminal justice system and that 63% of Americans support the Black Lives Matter movement." The Washington Examiner (7/21, Doyle, 448K) says the poll shows "most people in the United States" are "siding with President Trump on an issue over which he has been repe

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

filiate al-Shabaab and the local ISIS affiliate." COUNTER-INTELLIGENCE Michigan Woman Convicted In Tennessee Of Stealing Trade Secrets For China. The Washington Examiner (4/22, Dunleavy, 888K) reports, "A Chinese-born, naturalized U.S. citizen was convicted Thursday of stealing trade secrets worth up to $120 million

ipates "Some Form" Of HO Vaccine Resumption By Friday. NIAID Director Fauci, on CNN's State Of The UnionVi (4/18, 644K), discussed the pause on the Johnson & Johnson vaccine and overall vaccination efforts in the US. When asked about the decision to pause, Fauci said, "Because you want to make sure that you have

shuttering the prison's doors as well." COUNTER-INTELLIGENCE DO) Investigating If "Russiagate" Inquirer Kash Patel Leaked Classified Information. The Washington Examiner (4/16, Chaitin, 888K) reported the Justice Department is "investigating whether Kash Patel, a former high-ranking Trump Administration official who

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

and other minorities are denied equal treatment in the criminal justice system and that 63% of Americans support the Black Lives Matter movement." The Washington Examiner (7/21, Doyle, 448K) says the poll shows "most people in the United States" are "siding with President Trump on an issue over which he has been repe

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

plications, it only claimed that those inaccuracies did not ultimately affect the outcome of the Foreign Intelligence Surveillance Court's orders." The Washington Examiner (7/30, Dunleavy, 448K) reports that surveillance of former Trump campaign adviser Carter Page "appears to have been uniquely problematic." The FBI